Concordance between SARS-CoV-2 index individuals and their household contacts on index individual COVID-19 transmission cofactors: a comparison of self-reported and contact-reported information

被引:0
作者
Dahl, Angela M. [1 ]
Brown, Clare E. [2 ]
Brown, Elizabeth R. [1 ,3 ,4 ]
O'Brien, Meagan P. [5 ]
Barnabas, Ruanne V. [6 ]
机构
[1] Univ Washington, Dept Biostat, Seattle, WA 98195 USA
[2] Univ Washington, Dept Global Hlth, Seattle, WA USA
[3] Fred Hutchinson Canc Ctr, Vaccine & Infect Dis Div, Seattle, WA USA
[4] Fred Hutchinson Canc Ctr, Publ Hlth Sci Div, Seattle, WA USA
[5] Regeneron Pharmaceut, Tarrytown, NY USA
[6] Harvard Med Sch, Massachusetts Gen Hosp, Div Infect Dis, Boston, MA USA
关键词
COVID-19; SARS-CoV-2; Post-exposure prophylaxis; Household transmission; Self-reported; Behavior; BIAS;
D O I
10.1186/s12889-024-18371-7
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Following the outbreak of the COVID-19 pandemic, several clinical trials have evaluated postexposure prophylaxis (PEP) among close contacts of an index individual with a confirmed SARS-CoV-2 infection. Because index individuals do not directly inform the efficacy of prevention interventions, they are seldom enrolled in COVID-19 PEP studies. However, adjusting for prognostic covariates such as an index individual's COVID-19 illness and risk behaviors can increase precision in PEP efficacy estimates, so approaches to accurately collecting this information about the index individual are needed. This analysis aimed to assess whether surveying household contacts captures the same information as surveying the index individual directly.Methods REGN 2069/CoVPN 3502, a randomized controlled trial of COVID-19 PEP, enrolled household contacts of SARS-CoV-2 index individuals. CoVPN 3502-01 retrospectively enrolled and surveyed the index individuals. We compared responses to seven similar questions about the index individuals' transmission cofactors that were asked in both studies. We estimated the percent concordance between index individuals and their household contacts on each question, with 50% concordance considered equivalent to random chance.Results Concordance between index individuals and contacts was high on the most objective questions, approximately 97% (95% CI: 90-99%) for index individual age group and 96% (88-98%) for hospitalization. Concordance was moderate for symptoms, approximately 85% (75-91%). Concordance on questions related to the index individual's behavior was only slightly better or no better than random: approximately 62% (51-72%) for whether they received COVID-19 treatment, 68% (57-77%) for sharing a bedroom, 70% (59-79%) for sharing a common room, and 49% (39-60%) for mask wearing at home. However, while contacts were surveyed within 96 h of the index individual testing positive for SARS-CoV-2, the median time to enrollment in CoVPN 3502-01 was 240 days, which may have caused recall bias in our results.Conclusions Our results suggest a need to survey index individuals directly in order to accurately capture their transmission cofactors, rather than relying on their household contacts to report on their behavior. The lag in enrolling participants into CoVPN 3502-01 also highlights the importance of timely enrollment to minimize recall bias.
引用
收藏
页数:8
相关论文
共 20 条
[1]   Molnupiravir for intra-household prevention of COVID-19: The MOVe-AHEAD randomized, placebo-controlled trial [J].
Alpizar, Sady A. ;
Accini, Jose ;
Anderson, Duane C. ;
Eysa, Basem ;
Medina-Pinon, Isai ;
Ohmagari, Norio ;
Ostrovskyy, Mykola M. ;
Aggrey-Amable, Angela ;
Beck, Karen ;
Byrne, Dana ;
Grayson, Staci ;
Hwang, Peggy M. T. ;
Lonchar, Julia D. ;
Strizki, Julie ;
Xu, Yayun ;
Paschke, Amanda ;
De Anda, Carisa S. ;
Sears, Pamela S. .
JOURNAL OF INFECTION, 2023, 87 (05) :392-402
[2]   Information bias in health research: definition, pitfalls, and adjustment methods [J].
Althubaiti, Alaa .
JOURNAL OF MULTIDISCIPLINARY HEALTHCARE, 2016, 9 :211-217
[3]  
[Anonymous], 2023, COVID-19 Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults and Adolescents Who Are Household Contacts to an Individual With a Positive SARS-CoV-2 RT-PCR Assay
[4]   Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection A Randomized Trial [J].
Barnabas, Ruanne, V ;
Brown, Elizabeth R. ;
Bershteyn, Anna ;
Karita, Helen C. Stankiewicz ;
Johnston, Christine ;
Thorpe, Lorna E. ;
Kottkamp, Angelica ;
Neuzil, Kathleen M. ;
Laufer, Miriam K. ;
Deming, Meagan ;
Paasche-Orlow, Michael K. ;
Kissinger, Patricia J. ;
Luk, Alfred ;
Paolino, Kristopher ;
Landovitz, Raphael J. ;
Hoffman, Risa ;
Schaafsma, Torin T. ;
Krows, Meighan L. ;
Thomas, Katherine K. ;
Morrison, Susan ;
Haugen, Harald S. ;
Kidoguchi, Lara ;
Wener, Mark ;
Greninger, Alexander L. ;
Huang, Meei-Li ;
Jerome, Keith R. ;
Wald, Anna ;
Celum, Connie ;
Chu, Helen Y. ;
Baeten, Jared M. .
ANNALS OF INTERNAL MEDICINE, 2021, 174 (03) :344-+
[5]   Mode of questionnaire administration can have serious effects on data quality [J].
Bowling, A .
JOURNAL OF PUBLIC HEALTH, 2005, 27 (03) :281-291
[6]  
Center for Biologics Evaluation and Research and Center for Drug Evaluation and Research, 2018, E6(R2.) Good Clinical Practice: Integrated Addendum to ICH E6(R1)
[7]  
Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research, 2023, Adjusting for Covariates in Randomized Clinical Trials for Drugs and Biological Products: Guidance for Industry
[8]  
ClinicalTrials.gov, 2021, Index Individuals in SARS-CoV-2 Prevention Research Studies (COVID-19 Index Individuals Companion Study) (IICov19PRS)
[9]   Leveraging prognostic baseline variables to gain precision in randomized trials [J].
Colantuoni, Elizabeth ;
Rosenblum, Michael .
STATISTICS IN MEDICINE, 2015, 34 (18) :2602-2617
[10]   RECALL BIAS IN EPIDEMIOLOGIC STUDIES [J].
COUGHLIN, SS .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1990, 43 (01) :87-91